Development and Validation of CXCR4 Nomogram-Based Immune Infiltration/Tumor Inflammation in Primary Glioblastoma
Glioblastoma (GBM) is a highly malignant and aggressive tumor with poor prognosis. Therefore, the discovery of new prognostic molecular markers is of great significance for clinical prognosis. The CXC chemokine receptor (CXCR) members play a key regulatory role in many cancers. In this study, we exp...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/13/8/1152 |
_version_ | 1827730186931535872 |
---|---|
author | Guannan Jiang Zong-Qing Zheng Jie Zhang Zhichao Tian Xiang Li Zhengquan Yu Zhong Wang Wanchun You Gang Chen |
author_facet | Guannan Jiang Zong-Qing Zheng Jie Zhang Zhichao Tian Xiang Li Zhengquan Yu Zhong Wang Wanchun You Gang Chen |
author_sort | Guannan Jiang |
collection | DOAJ |
description | Glioblastoma (GBM) is a highly malignant and aggressive tumor with poor prognosis. Therefore, the discovery of new prognostic molecular markers is of great significance for clinical prognosis. The CXC chemokine receptor (CXCR) members play a key regulatory role in many cancers. In this study, we explore the clinical value and application of the CXCR members in primary glioblastoma. Two GBM datasets from The Cancer Genome Atlas (TCGA) and The China Glioma Genome Atlas (CGGA) databases were used to explore the relationship between differential expression of CXCRs and GBM subtypes as well as immune infiltration. C-X-C motif chemokine receptor 4 (CXCR4) was screened as an independent prognostic factor, and a nomogram and risk prediction model were developed and tested in the CGGA database using the TCGA database. Receiver operating curve (ROC) and decision curve analysis (DCA) found good accuracy and net benefit of the models. The correlation of CXCR4 with immune infiltration and tumor was analyzed using CancerSEA and TIMER. In in vitro experiments, we found that CXCR4 was significantly overexpressed in glioblastoma and was closely related to the inflammatory response of U251/U87 cells. CXCR4 is an excellent independent prognostic factor for glioblastoma and positively correlates with tumor inflammation. |
first_indexed | 2024-03-11T00:05:40Z |
format | Article |
id | doaj.art-ac02f189c84e4b77afcb2fa4cac7ba42 |
institution | Directory Open Access Journal |
issn | 2076-3425 |
language | English |
last_indexed | 2024-03-11T00:05:40Z |
publishDate | 2023-08-01 |
publisher | MDPI AG |
record_format | Article |
series | Brain Sciences |
spelling | doaj.art-ac02f189c84e4b77afcb2fa4cac7ba422023-11-19T00:26:30ZengMDPI AGBrain Sciences2076-34252023-08-01138115210.3390/brainsci13081152Development and Validation of CXCR4 Nomogram-Based Immune Infiltration/Tumor Inflammation in Primary GlioblastomaGuannan Jiang0Zong-Qing Zheng1Jie Zhang2Zhichao Tian3Xiang Li4Zhengquan Yu5Zhong Wang6Wanchun You7Gang Chen8Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaDepartment of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, ChinaGlioblastoma (GBM) is a highly malignant and aggressive tumor with poor prognosis. Therefore, the discovery of new prognostic molecular markers is of great significance for clinical prognosis. The CXC chemokine receptor (CXCR) members play a key regulatory role in many cancers. In this study, we explore the clinical value and application of the CXCR members in primary glioblastoma. Two GBM datasets from The Cancer Genome Atlas (TCGA) and The China Glioma Genome Atlas (CGGA) databases were used to explore the relationship between differential expression of CXCRs and GBM subtypes as well as immune infiltration. C-X-C motif chemokine receptor 4 (CXCR4) was screened as an independent prognostic factor, and a nomogram and risk prediction model were developed and tested in the CGGA database using the TCGA database. Receiver operating curve (ROC) and decision curve analysis (DCA) found good accuracy and net benefit of the models. The correlation of CXCR4 with immune infiltration and tumor was analyzed using CancerSEA and TIMER. In in vitro experiments, we found that CXCR4 was significantly overexpressed in glioblastoma and was closely related to the inflammatory response of U251/U87 cells. CXCR4 is an excellent independent prognostic factor for glioblastoma and positively correlates with tumor inflammation.https://www.mdpi.com/2076-3425/13/8/1152glioblastomaC-X-C motif chemokine receptor 4nomograminflammationimmune-cell infiltration |
spellingShingle | Guannan Jiang Zong-Qing Zheng Jie Zhang Zhichao Tian Xiang Li Zhengquan Yu Zhong Wang Wanchun You Gang Chen Development and Validation of CXCR4 Nomogram-Based Immune Infiltration/Tumor Inflammation in Primary Glioblastoma Brain Sciences glioblastoma C-X-C motif chemokine receptor 4 nomogram inflammation immune-cell infiltration |
title | Development and Validation of CXCR4 Nomogram-Based Immune Infiltration/Tumor Inflammation in Primary Glioblastoma |
title_full | Development and Validation of CXCR4 Nomogram-Based Immune Infiltration/Tumor Inflammation in Primary Glioblastoma |
title_fullStr | Development and Validation of CXCR4 Nomogram-Based Immune Infiltration/Tumor Inflammation in Primary Glioblastoma |
title_full_unstemmed | Development and Validation of CXCR4 Nomogram-Based Immune Infiltration/Tumor Inflammation in Primary Glioblastoma |
title_short | Development and Validation of CXCR4 Nomogram-Based Immune Infiltration/Tumor Inflammation in Primary Glioblastoma |
title_sort | development and validation of cxcr4 nomogram based immune infiltration tumor inflammation in primary glioblastoma |
topic | glioblastoma C-X-C motif chemokine receptor 4 nomogram inflammation immune-cell infiltration |
url | https://www.mdpi.com/2076-3425/13/8/1152 |
work_keys_str_mv | AT guannanjiang developmentandvalidationofcxcr4nomogrambasedimmuneinfiltrationtumorinflammationinprimaryglioblastoma AT zongqingzheng developmentandvalidationofcxcr4nomogrambasedimmuneinfiltrationtumorinflammationinprimaryglioblastoma AT jiezhang developmentandvalidationofcxcr4nomogrambasedimmuneinfiltrationtumorinflammationinprimaryglioblastoma AT zhichaotian developmentandvalidationofcxcr4nomogrambasedimmuneinfiltrationtumorinflammationinprimaryglioblastoma AT xiangli developmentandvalidationofcxcr4nomogrambasedimmuneinfiltrationtumorinflammationinprimaryglioblastoma AT zhengquanyu developmentandvalidationofcxcr4nomogrambasedimmuneinfiltrationtumorinflammationinprimaryglioblastoma AT zhongwang developmentandvalidationofcxcr4nomogrambasedimmuneinfiltrationtumorinflammationinprimaryglioblastoma AT wanchunyou developmentandvalidationofcxcr4nomogrambasedimmuneinfiltrationtumorinflammationinprimaryglioblastoma AT gangchen developmentandvalidationofcxcr4nomogrambasedimmuneinfiltrationtumorinflammationinprimaryglioblastoma |